LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Effect of Antigen Valency on Autoreactive B-Cell Targeting.

van Weijsten, M J / Venrooij, K R / Lelieveldt, L P W M / Kissel, T / van Buijtenen, E / van Dalen, F J / Verdoes, M / Toes, R E M / Bonger, K M

Molecular pharmaceutics

2023  Volume 21, Issue 2, Page(s) 481–490

Abstract: Many autoimmune diseases are characterized by B cells that mistakenly recognize autoantigens and produce antibodies toward self-proteins. Current therapies aim to suppress the immune system, which is associated with adverse effects. An attractive and ... ...

Abstract Many autoimmune diseases are characterized by B cells that mistakenly recognize autoantigens and produce antibodies toward self-proteins. Current therapies aim to suppress the immune system, which is associated with adverse effects. An attractive and more specific approach is to target the autoreactive B cells selectively through their unique B-cell receptor (BCR) using an autoantigen coupled to an effector molecule able to modulate the B-cell activity. The cellular response upon antigen binding, such as receptor internalization, impacts the choice of effector molecule. In this study, we systematically investigated how a panel of well-defined mono-, di-, tetra-, and octavalent peptide antigens affects the binding, activation, and internalization of the BCR. To test our constructs, we used a B-cell line expressing a BCR against citrullinated antigens, the main autoimmune epitope in rheumatoid arthritis. We found that the dimeric antigen construct has superior targeting properties compared to those of its monomeric and multimeric counterparts, indicating that it can serve as a basis for future antigen-specific targeting studies for the treatment of RA.
MeSH term(s) Humans ; B-Lymphocytes/metabolism ; Receptors, Antigen, B-Cell/metabolism ; Arthritis, Rheumatoid ; Peptides/metabolism ; Autoantigens
Chemical Substances Receptors, Antigen, B-Cell ; Peptides ; Autoantigens
Language English
Publishing date 2023-10-20
Publishing country United States
Document type Journal Article
ZDB-ID 2138405-8
ISSN 1543-8392 ; 1543-8384
ISSN (online) 1543-8392
ISSN 1543-8384
DOI 10.1021/acs.molpharmaceut.3c00527
Shelf mark
Zs.A 6250: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top